Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bausch Health Companies Inc
(NY:
BHC
)
8.710
+0.090 (+1.04%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bausch Health Companies Inc
< Previous
1
2
3
4
5
Next >
Bausch Health Companies Inc. (BHC) Class Action Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline in Class Action Against Bausch Health Companies Inc.
August 02, 2023
From
Robbins LLP
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Bausch Health Companies Inc. (BHC) Investors
August 02, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
BHC INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Bausch Health Companies Inc. Investors with Substantial Losses Have Opportunity to Lead the Bausch Health Class Action Lawsuit
August 02, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients
July 27, 2023
Via
ACCESSWIRE
BHC DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.
August 02, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Bausch Health Companies Inc. (BHC) Investors
August 01, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Bausch Health Companies Inc. (BHC) Investors
August 01, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
July 11, 2023
Via
ACCESSWIRE
Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL's International Liver Congress(TM) 2023
June 19, 2023
Via
ACCESSWIRE
Bausch Health Announces 2023 Annual Meeting of Shareholder Results
May 17, 2023
Via
ACCESSWIRE
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Bausch Health Companies Inc. (BHC) on Behalf of Investors
July 31, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Bausch Health Companies Inc. (BHC) on Behalf of Investors
July 28, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Bausch Health Companies Inc. (BHC) on Behalf of Investors
July 28, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023
May 08, 2023
Via
ACCESSWIRE
Bausch Health Announces First-Quarter 2023 Results
May 04, 2023
Via
ACCESSWIRE
Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel
May 01, 2023
Via
ACCESSWIRE
BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.
July 28, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Bausch Health Companies Inc. (BHC)
July 27, 2023
From
Robbins LLP
Via
Business Wire
BHC EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BHC
July 27, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
Salix Partners with the Colorectal Cancer Alliance on Community Screening Program
April 24, 2023
Via
ACCESSWIRE
Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3
July 13, 2023
Via
ACCESSWIRE
OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services(R) at the American Dental Hygienists' Association (ADHA(R)) Annual Conference
July 07, 2023
Via
ACCESSWIRE
Bausch Health Enters Into $600 Million Financing Facility With KKR
July 07, 2023
Via
ACCESSWIRE
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
June 30, 2023
Via
ACCESSWIRE
Bausch Health Responds to Norwich's ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration
June 06, 2023
Via
ACCESSWIRE
Zoetis Declares New Dividend, Hinting At Undervaluation
May 18, 2023
Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally
Via
MarketBeat
New Clinical Study Suggests the Use of OraPharma’s ARESTIN(R) (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis
May 18, 2023
Via
ACCESSWIRE
U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
May 17, 2023
Via
ACCESSWIRE
Bausch Health Observes Mental Health Awareness Month
May 10, 2023
Via
ACCESSWIRE
New Artificial Intelligence Tool Can Diagnose Colon Cancer
May 03, 2023
A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and...
Via
PressReach
Topics
Artificial Intelligence
Death
Exposures
Artificial Intelligence
Death
Product Safety
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.